INFUSYSTEM HOLDINGS INC (INFU) Stock Fundamental Analysis
USA - NYSEARCA:INFU - US45685K1025 - Common Stock
10.085 USD
-0.27 (-2.65%)
Taking everything into account, INFU scores 6 out of 10 in our fundamental rating. INFU was compared to 101 industry peers in the Health Care Providers & Services industry. INFU scores excellent points on both the profitability and health parts. This is a solid base for a good stock. INFU is not valued too expensively and it also shows a decent growth rate. These ratings could make INFU a good candidate for quality investing.
1. Profitability
1.1 Basic Checks
In the past year INFU was profitable.
In the past year INFU had a positive cash flow from operations.
Each year in the past 5 years INFU has been profitable.
INFU had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
The Return On Assets of INFU (5.03%) is better than 77.23% of its industry peers.
INFU's Return On Equity of 9.30% is fine compared to the rest of the industry. INFU outperforms 72.28% of its industry peers.
INFU's Return On Invested Capital of 9.55% is amongst the best of the industry. INFU outperforms 80.20% of its industry peers.
INFU had an Average Return On Invested Capital over the past 3 years of 3.86%. This is significantly below the industry average of 9.19%.
The last Return On Invested Capital (9.55%) for INFU is above the 3 year average (3.86%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.03% | ||
| ROE | 9.3% | ||
| ROIC | 9.55% |
ROA(3y)1.04%
ROA(5y)4.49%
ROE(3y)1.93%
ROE(5y)10.25%
ROIC(3y)3.86%
ROIC(5y)4.73%
1.3 Margins
INFU's Profit Margin of 3.63% is fine compared to the rest of the industry. INFU outperforms 69.31% of its industry peers.
INFU's Profit Margin has been stable in the last couple of years.
With a decent Operating Margin value of 7.35%, INFU is doing good in the industry, outperforming 73.27% of the companies in the same industry.
In the last couple of years the Operating Margin of INFU has grown nicely.
INFU has a better Gross Margin (54.55%) than 77.23% of its industry peers.
INFU's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 7.35% | ||
| PM (TTM) | 3.63% | ||
| GM | 54.55% |
OM growth 3Y22.87%
OM growth 5Y3.29%
PM growth 3Y7.83%
PM growth 5Y0.72%
GM growth 3Y-3.89%
GM growth 5Y-2.01%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so INFU is still creating some value.
INFU has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, INFU has more shares outstanding
INFU has a better debt/assets ratio than last year.
2.2 Solvency
INFU has an Altman-Z score of 3.84. This indicates that INFU is financially healthy and has little risk of bankruptcy at the moment.
With a decent Altman-Z score value of 3.84, INFU is doing good in the industry, outperforming 72.28% of the companies in the same industry.
INFU has a debt to FCF ratio of 1.97. This is a very positive value and a sign of high solvency as it would only need 1.97 years to pay back of all of its debts.
With an excellent Debt to FCF ratio value of 1.97, INFU belongs to the best of the industry, outperforming 83.17% of the companies in the same industry.
A Debt/Equity ratio of 0.48 indicates that INFU is not too dependend on debt financing.
INFU's Debt to Equity ratio of 0.48 is fine compared to the rest of the industry. INFU outperforms 61.39% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.48 | ||
| Debt/FCF | 1.97 | ||
| Altman-Z | 3.84 |
ROIC/WACC1.09
WACC8.73%
2.3 Liquidity
A Current Ratio of 2.19 indicates that INFU has no problem at all paying its short term obligations.
The Current ratio of INFU (2.19) is better than 77.23% of its industry peers.
A Quick Ratio of 1.84 indicates that INFU should not have too much problems paying its short term obligations.
With a decent Quick ratio value of 1.84, INFU is doing good in the industry, outperforming 70.30% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.19 | ||
| Quick Ratio | 1.84 |
3. Growth
3.1 Past
INFU shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 1816.67%, which is quite impressive.
INFU shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 10.59% yearly.
INFU shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 8.13%.
The Revenue has been growing by 10.70% on average over the past years. This is quite good.
EPS 1Y (TTM)1816.67%
EPS 3Y12.62%
EPS 5Y10.59%
EPS Q2Q%300%
Revenue 1Y (TTM)8.13%
Revenue growth 3Y9.62%
Revenue growth 5Y10.7%
Sales Q2Q%6.84%
3.2 Future
The Earnings Per Share is expected to grow by 68.50% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 7.69% on average over the next years.
EPS Next Y160.1%
EPS Next 2Y97.91%
EPS Next 3Y68.5%
EPS Next 5YN/A
Revenue Next Year6.09%
Revenue Next 2Y6.32%
Revenue Next 3Y7.69%
Revenue Next 5YN/A
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
INFU is valuated quite expensively with a Price/Earnings ratio of 43.85.
INFU's Price/Earnings is on the same level as the industry average.
INFU's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 27.76.
The Price/Forward Earnings ratio is 25.75, which means the current valuation is very expensive for INFU.
Compared to the rest of the industry, the Price/Forward Earnings ratio of INFU is on the same level as its industry peers.
The average S&P500 Price/Forward Earnings ratio is at 23.18. INFU is around the same levels.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 43.85 | ||
| Fwd PE | 25.75 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, INFU is valued a bit cheaper than 72.28% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, INFU is valued a bit cheaper than 77.23% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 15.4 | ||
| EV/EBITDA | 10.1 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of INFU may justify a higher PE ratio.
INFU's earnings are expected to grow with 68.50% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.27
PEG (5Y)4.14
EPS Next 2Y97.91%
EPS Next 3Y68.5%
5. Dividend
5.1 Amount
No dividends for INFU!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
NYSEARCA:INFU (10/1/2025, 12:35:58 PM)
10.085
-0.27 (-2.65%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners75.26%
Inst Owner Change-3.29%
Ins Owners4.59%
Ins Owner Change0.86%
Market Cap206.04M
Analysts83.64
Price Target13.6 (34.85%)
Short Float %0.75%
Short Ratio0.54
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)151.14%
Min EPS beat(2)75.49%
Max EPS beat(2)226.8%
EPS beat(4)3
Avg EPS beat(4)69.56%
Min EPS beat(4)-48.06%
Max EPS beat(4)226.8%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-0.63%
Min Revenue beat(2)-2.26%
Max Revenue beat(2)0.99%
Revenue beat(4)2
Avg Revenue beat(4)-1.44%
Min Revenue beat(4)-4.92%
Max Revenue beat(4)0.99%
Revenue beat(8)4
Avg Revenue beat(8)-0.36%
Revenue beat(12)6
Avg Revenue beat(12)-0.46%
Revenue beat(16)7
Avg Revenue beat(16)-1.59%
PT rev (1m)6.67%
PT rev (3m)-2.14%
EPS NQ rev (1m)-3.12%
EPS NQ rev (3m)1.53%
EPS NY rev (1m)0%
EPS NY rev (3m)44.34%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-1.28%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.81%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 43.85 | ||
| Fwd PE | 25.75 | ||
| P/S | 1.47 | ||
| P/FCF | 15.4 | ||
| P/OCF | 7.76 | ||
| P/B | 3.78 | ||
| P/tB | 4.72 | ||
| EV/EBITDA | 10.1 |
EPS(TTM)0.23
EY2.28%
EPS(NY)0.39
Fwd EY3.88%
FCF(TTM)0.66
FCFY6.49%
OCF(TTM)1.3
OCFY12.89%
SpS6.85
BVpS2.67
TBVpS2.14
PEG (NY)0.27
PEG (5Y)4.14
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.03% | ||
| ROE | 9.3% | ||
| ROCE | 12.09% | ||
| ROIC | 9.55% | ||
| ROICexc | 9.63% | ||
| ROICexgc | 11.06% | ||
| OM | 7.35% | ||
| PM (TTM) | 3.63% | ||
| GM | 54.55% | ||
| FCFM | 9.57% |
ROA(3y)1.04%
ROA(5y)4.49%
ROE(3y)1.93%
ROE(5y)10.25%
ROIC(3y)3.86%
ROIC(5y)4.73%
ROICexc(3y)3.88%
ROICexc(5y)5.02%
ROICexgc(3y)4.43%
ROICexgc(5y)5.92%
ROCE(3y)4.88%
ROCE(5y)5.98%
ROICexcg growth 3Y31.39%
ROICexcg growth 5Y0.4%
ROICexc growth 3Y34.21%
ROICexc growth 5Y4.6%
OM growth 3Y22.87%
OM growth 5Y3.29%
PM growth 3Y7.83%
PM growth 5Y0.72%
GM growth 3Y-3.89%
GM growth 5Y-2.01%
F-Score9
Asset Turnover1.39
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.48 | ||
| Debt/FCF | 1.97 | ||
| Debt/EBITDA | 1.12 | ||
| Cap/Depr | 99.64% | ||
| Cap/Sales | 9.42% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 113.02% | ||
| Profit Quality | 263.84% | ||
| Current Ratio | 2.19 | ||
| Quick Ratio | 1.84 | ||
| Altman-Z | 3.84 |
F-Score9
WACC8.73%
ROIC/WACC1.09
Cap/Depr(3y)114.8%
Cap/Depr(5y)115.78%
Cap/Sales(3y)11.93%
Cap/Sales(5y)13.88%
Profit Quality(3y)4561.75%
Profit Quality(5y)2764.31%
High Growth Momentum
Growth
EPS 1Y (TTM)1816.67%
EPS 3Y12.62%
EPS 5Y10.59%
EPS Q2Q%300%
EPS Next Y160.1%
EPS Next 2Y97.91%
EPS Next 3Y68.5%
EPS Next 5YN/A
Revenue 1Y (TTM)8.13%
Revenue growth 3Y9.62%
Revenue growth 5Y10.7%
Sales Q2Q%6.84%
Revenue Next Year6.09%
Revenue Next 2Y6.32%
Revenue Next 3Y7.69%
Revenue Next 5YN/A
EBIT growth 1Y159.69%
EBIT growth 3Y34.69%
EBIT growth 5Y14.35%
EBIT Next Year309.04%
EBIT Next 3Y71.57%
EBIT Next 5YN/A
FCF growth 1Y355.58%
FCF growth 3Y16.52%
FCF growth 5YN/A
OCF growth 1Y157.31%
OCF growth 3Y3.76%
OCF growth 5Y8.08%